Product Details for NDA 018649
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER (THEOPHYLLINE)
4MG/ML
Marketing Status: Discontinued
40MG/100ML
Marketing Status: Discontinued
80MG/100ML
Marketing Status: Discontinued
160MG/100ML
Marketing Status: Discontinued
200MG/100ML
Marketing Status: Discontinued
320MG/100ML
Marketing Status: Discontinued
400MG/100ML
Marketing Status: Discontinued
4MG/ML
Marketing Status: Discontinued
Active Ingredient: THEOPHYLLINE
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 007
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER (THEOPHYLLINE)
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 007
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
40MG/100ML
Marketing Status: Discontinued
Active Ingredient: THEOPHYLLINE
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 001
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER (THEOPHYLLINE)
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 001
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
80MG/100ML
Marketing Status: Discontinued
Active Ingredient: THEOPHYLLINE
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 002
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER (THEOPHYLLINE)
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 002
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
160MG/100ML
Marketing Status: Discontinued
Active Ingredient: THEOPHYLLINE
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 160MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 003
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER (THEOPHYLLINE)
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 160MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 003
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
200MG/100ML
Marketing Status: Discontinued
Active Ingredient: THEOPHYLLINE
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 004
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER (THEOPHYLLINE)
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 004
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
320MG/100ML
Marketing Status: Discontinued
Active Ingredient: THEOPHYLLINE
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 320MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 006
Approval Date: Nov 13, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER (THEOPHYLLINE)
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 320MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 006
Approval Date: Nov 13, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
400MG/100ML
Marketing Status: Discontinued
Active Ingredient: THEOPHYLLINE
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 400MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 005
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 400MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018649
Product Number: 005
Approval Date: Jul 26, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Discontinued
Patent and Exclusivity Information